Veradigm | MDRX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alcidion AUD 11.8M 2.84M 2024-06
Ambu A/S DKK 691M 44M 2026-03
Amplifon EUR 309.56M 673K 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Centene USD 21.26B 3.38B 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Cigna USD 7.04B 636M 2026-03
Coloplast 911M 497M 2023-09
Computer Programs Systems USD 24.85M 4.93M 2025-12
Convatec Group USD 64.7M 32.2M 2024-12
CVS Health USD 9.54B 1.09B 2026-03
Diasorin EUR 173.08M 3.51M 2025-06
Elevance Health USD 9.66B 166M 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Gulf Medical Proj AED 74.52M 101.52M 2025-03
Humana USD 4.95B 751M 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Maximus USD 157.45M 19.86M 2026-03
McKesson USD 3.98B 1.02B 2026-03
Med Life RON 185.35M 35.79M 2025-09
Molina Healthcare USD 5.31B 1.07B 2026-03
Omnicell USD 239.22M 42.7M 2026-03
Oriola-kd EUR 107.6M 13.9M 2025-09
Owens Minor USD 336.88M 54.89M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Rede D'or Sao Luiz BRL 5.41B 1.7B 2026-03
Siemens Healthineers EUR 2.14B 231M 2025-12
Sonova Holding CHF 413.9M 134.3M 2023-06
Supermax Corporation Bhd MYR 637.59M 217.66M 2026-03
UnitedHealth USD 31.23B 3.11B 2026-03
Veeva Systems USD 1.9B 475.35M 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Xerox USD 585M 73M 2026-03